Assessing Whether Kazia Therapeutics Limited ADR (NASDAQ: KZIA) Is Over- Or Undervalued
Kazia Therapeutics Limited ADR (KZIA) concluded trading on Thursday at a closing price of $0.53, with 16.83 million shares of worth about $8.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 52.20% during that period and on October 17, 2024 the price saw […]
Is Kazia Therapeutics Limited ADR (NASDAQ: KZIA) Proving The Doubters Wrong?
Kazia Therapeutics Limited ADR (KZIA) concluded trading on Wednesday at a closing price of $0.32, with 20.42 million shares of worth about $6.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -65.97% during that period and on Wednesday the price saw a loss […]
Kazia Therapeutics Limited ADR (KZIA): Insights At A Glance
After grabbing 11639.0 shares, the institutional investor is now in possession of 11639.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.04% having worth around $5121.0. Moreover, BNP Paribas Financial Markets increased its share by 5202.0 to have a control over 8500.0 shares. And McGlone Suttner Wealth Management […]
